0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Lancets Market Research Report 2026
Published Date: 2026-02-05
|
Report Code: QYRE-Auto-23G2383
Home | Market Reports
Global Lancets Market Insights Forecast to 2026
BUY CHAPTERS

Global Lancets Market Research Report 2026

Code: QYRE-Auto-23G2383
Report
2026-02-05
Pages:147
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Lancets Market Size

The global Lancets market was valued at US$ 1723 million in 2025 and is anticipated to reach US$ 2112 million by 2032, at a CAGR of 3.0% from 2026 to 2032.

Lancets Market

Lancets Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Lancets competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Lancets are a pricking needle used to obtain drops of blood for testing. Lancets are being increasingly used by patients affected by cardiovascular and endocrine-related complications. Lancets are designed to only be used once, and then disposed of in a safe way. These devices are being used for cholesterol and glucose tests, heelstick screening tests or phenylketonuria (PKU) tests in newborns, as well as for severely burned or scarred emergency patients, extremely obese patients and thrombotic-tendency patients.In 2024, global Lancets production reached approximately 55.37 billion units, with an average global market price of around 30.22 US$ / k unit.
Market Drivers:
Growing prevalence of chronic diseases: The rise in chronic conditions like diabetes, which require regular blood glucose monitoring, is a significant driver for lancet demand. As the number of diabetes patients increases globally, the need for lancets continues to grow.
Technological advancements in lancets: Innovations such as ultra-thin needles, painless lancet designs, and easy-to-use lancet devices improve user experience, making blood sampling more comfortable and encouraging more frequent use.
Increase in home-based healthcare: The trend toward home healthcare and self-monitoring for various conditions, especially diabetes, has driven the use of lancets. This allows patients to monitor their health in a more convenient and cost-effective way, increasing the market for these devices.
Aging population: The growing elderly population is more prone to chronic diseases like diabetes, requiring regular blood monitoring. This demographic shift is a major factor pushing the demand for lancets and other monitoring devices.
Rising awareness of preventive healthcare: Increasing awareness of the importance of regular health monitoring, especially for managing conditions like diabetes, has led to higher adoption of lancets for routine blood tests and glucose monitoring.
Market Challenges:
Competition from alternative technologies: Non-invasive blood glucose monitoring methods (such as continuous glucose monitors or sensor-based systems) are gaining traction, potentially reducing the reliance on traditional lancets for blood sampling.
High recurring costs for patients: Lancets are single-use devices, and the recurring cost for people who need frequent testing can become a financial burden, particularly in low-income regions or for uninsured patients, limiting market growth.
Infection risks: Improper or repeated use of lancets can lead to infections, particularly if they are not disposed of properly or if reused by mistake, which poses a health risk and deters their use.
Environmental concerns: Lancets contribute to medical waste, as they are disposable devices, raising concerns about environmental impact. This could lead to regulatory pressures or a shift toward more sustainable alternatives.
Regulatory compliance and approval hurdles: The lancet market is subject to stringent regulations and approval processes from health authorities. This can slow down the introduction of new products and innovations, delaying their availability in the market.
This report delivers a comprehensive overview of the global Lancets market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Lancets. The Lancets market size, estimates, and forecasts are provided in terms of sales volume (M Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Lancets market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Lancets manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Lancets Market Report

Report Metric Details
Report Name Lancets Market
Accounted market size in 2025 US$ 1723 in million
Forecasted market size in 2032 US$ 2112 million
CAGR 3.0%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Safety Lancets
  • Ordinary Lancets
by Application
  • Blood Glucose Test
  • Newborn Screening
  • Rapid Blood Test
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Roche, Lifescan, BD, MTD Group, Greiner Bio One, Owen Mumford, Cardinal Health, Ascensia, Abbott, B. Braun, Terumo, I-SENS, Nipro, ICU Medical, Sarstedt, Sinocare, Yueyue Medical, Tianjin Huahong Medical, Suzhou Shilai Medical, Shandong Lianfa Medical, Promisemed
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Lancets manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Lancets sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Lancets Market growing?

Ans: The Lancets Market witnessing a CAGR of 3.0% during the forecast period 2026-2032.

What is the Lancets Market size in 2032?

Ans: The Lancets Market size in 2032 will be US$ 2112 million.

Who are the main players in the Lancets Market report?

Ans: The main players in the Lancets Market are Roche, Lifescan, BD, MTD Group, Greiner Bio One, Owen Mumford, Cardinal Health, Ascensia, Abbott, B. Braun, Terumo, I-SENS, Nipro, ICU Medical, Sarstedt, Sinocare, Yueyue Medical, Tianjin Huahong Medical, Suzhou Shilai Medical, Shandong Lianfa Medical, Promisemed

What are the Application segmentation covered in the Lancets Market report?

Ans: The Applications covered in the Lancets Market report are Blood Glucose Test, Newborn Screening, Rapid Blood Test, Other

What are the Type segmentation covered in the Lancets Market report?

Ans: The Types covered in the Lancets Market report are Safety Lancets, Ordinary Lancets

1 Lancets Market Overview
1.1 Product Definition
1.2 Lancets by Type
1.2.1 Global Lancets Market Value by Type: 2025 vs 2032
1.2.2 Safety Lancets
1.2.3 Ordinary Lancets
1.3 Lancets by Application
1.3.1 Global Lancets Market Value by Application: 2025 vs 2032
1.3.2 Blood Glucose Test
1.3.3 Newborn Screening
1.3.4 Rapid Blood Test
1.3.5 Other
1.4 Global Lancets Market Size Estimates and Forecasts
1.4.1 Global Lancets Revenue 2021–2032
1.4.2 Global Lancets Sales 2021–2032
1.4.3 Global Lancets Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Lancets Market Competition by Manufacturers
2.1 Global Lancets Sales Market Share by Manufacturers (2021–2026)
2.2 Global Lancets Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Lancets Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Lancets, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Lancets, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Lancets, Product Types and Applications
2.7 Global Key Manufacturers of Lancets, Date of Entry into the Industry
2.8 Global Lancets Market Competitive Situation and Trends
2.8.1 Global Lancets Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Lancets Players Market Share by Revenue
2.8.3 Global Lancets Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Lancets Market Scenario by Region
3.1 Global Lancets Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Lancets Sales by Region: 2021–2032
3.2.1 Global Lancets Sales by Region: 2021–2026
3.2.2 Global Lancets Sales by Region: 2027–2032
3.3 Global Lancets Revenue by Region: 2021–2032
3.3.1 Global Lancets Revenue by Region: 2021–2026
3.3.2 Global Lancets Revenue by Region: 2027–2032
3.4 North America Lancets Market Facts & Figures by Country
3.4.1 North America Lancets Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Lancets Sales by Country (2021–2032)
3.4.3 North America Lancets Revenue by Country (2021–2032)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Lancets Market Facts & Figures by Country
3.5.1 Europe Lancets Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Lancets Sales by Country (2021–2032)
3.5.3 Europe Lancets Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Lancets Market Facts & Figures by Region
3.6.1 Asia Pacific Lancets Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Lancets Sales by Region (2021–2032)
3.6.3 Asia Pacific Lancets Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Lancets Market Facts & Figures by Country
3.7.1 Latin America Lancets Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Lancets Sales by Country (2021–2032)
3.7.3 Latin America Lancets Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Lancets Market Facts & Figures by Country
3.8.1 Middle East and Africa Lancets Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Lancets Sales by Country (2021–2032)
3.8.3 Middle East and Africa Lancets Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Lancets Sales by Type (2021–2032)
4.1.1 Global Lancets Sales by Type (2021–2026)
4.1.2 Global Lancets Sales by Type (2027–2032)
4.1.3 Global Lancets Sales Market Share by Type (2021–2032)
4.2 Global Lancets Revenue by Type (2021–2032)
4.2.1 Global Lancets Revenue by Type (2021–2026)
4.2.2 Global Lancets Revenue by Type (2027–2032)
4.2.3 Global Lancets Revenue Market Share by Type (2021–2032)
4.3 Global Lancets Price by Type (2021–2032)
5 Segment by Application
5.1 Global Lancets Sales by Application (2021–2032)
5.1.1 Global Lancets Sales by Application (2021–2026)
5.1.2 Global Lancets Sales by Application (2027–2032)
5.1.3 Global Lancets Sales Market Share by Application (2021–2032)
5.2 Global Lancets Revenue by Application (2021–2032)
5.2.1 Global Lancets Revenue by Application (2021–2026)
5.2.2 Global Lancets Revenue by Application (2027–2032)
5.2.3 Global Lancets Revenue Market Share by Application (2021–2032)
5.3 Global Lancets Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Roche
6.1.1 Roche Company Information
6.1.2 Roche Description and Business Overview
6.1.3 Roche Lancets Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Roche Lancets Product Portfolio
6.1.5 Roche Recent Developments/Updates
6.2 Lifescan
6.2.1 Lifescan Company Information
6.2.2 Lifescan Description and Business Overview
6.2.3 Lifescan Lancets Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Lifescan Lancets Product Portfolio
6.2.5 Lifescan Recent Developments/Updates
6.3 BD
6.3.1 BD Company Information
6.3.2 BD Description and Business Overview
6.3.3 BD Lancets Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 BD Lancets Product Portfolio
6.3.5 BD Recent Developments/Updates
6.4 MTD Group
6.4.1 MTD Group Company Information
6.4.2 MTD Group Description and Business Overview
6.4.3 MTD Group Lancets Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 MTD Group Lancets Product Portfolio
6.4.5 MTD Group Recent Developments/Updates
6.5 Greiner Bio One
6.5.1 Greiner Bio One Company Information
6.5.2 Greiner Bio One Description and Business Overview
6.5.3 Greiner Bio One Lancets Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Greiner Bio One Lancets Product Portfolio
6.5.5 Greiner Bio One Recent Developments/Updates
6.6 Owen Mumford
6.6.1 Owen Mumford Company Information
6.6.2 Owen Mumford Description and Business Overview
6.6.3 Owen Mumford Lancets Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Owen Mumford Lancets Product Portfolio
6.6.5 Owen Mumford Recent Developments/Updates
6.7 Cardinal Health
6.7.1 Cardinal Health Company Information
6.7.2 Cardinal Health Description and Business Overview
6.7.3 Cardinal Health Lancets Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Cardinal Health Lancets Product Portfolio
6.7.5 Cardinal Health Recent Developments/Updates
6.8 Ascensia
6.8.1 Ascensia Company Information
6.8.2 Ascensia Description and Business Overview
6.8.3 Ascensia Lancets Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Ascensia Lancets Product Portfolio
6.8.5 Ascensia Recent Developments/Updates
6.9 Abbott
6.9.1 Abbott Company Information
6.9.2 Abbott Description and Business Overview
6.9.3 Abbott Lancets Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Abbott Lancets Product Portfolio
6.9.5 Abbott Recent Developments/Updates
6.10 B. Braun
6.10.1 B. Braun Company Information
6.10.2 B. Braun Description and Business Overview
6.10.3 B. Braun Lancets Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 B. Braun Lancets Product Portfolio
6.10.5 B. Braun Recent Developments/Updates
6.11 Terumo
6.11.1 Terumo Company Information
6.11.2 Terumo Description and Business Overview
6.11.3 Terumo Lancets Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Terumo Lancets Product Portfolio
6.11.5 Terumo Recent Developments/Updates
6.12 I-SENS
6.12.1 I-SENS Company Information
6.12.2 I-SENS Description and Business Overview
6.12.3 I-SENS Lancets Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 I-SENS Lancets Product Portfolio
6.12.5 I-SENS Recent Developments/Updates
6.13 Nipro
6.13.1 Nipro Company Information
6.13.2 Nipro Description and Business Overview
6.13.3 Nipro Lancets Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Nipro Lancets Product Portfolio
6.13.5 Nipro Recent Developments/Updates
6.14 ICU Medical
6.14.1 ICU Medical Company Information
6.14.2 ICU Medical Description and Business Overview
6.14.3 ICU Medical Lancets Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 ICU Medical Lancets Product Portfolio
6.14.5 ICU Medical Recent Developments/Updates
6.15 Sarstedt
6.15.1 Sarstedt Company Information
6.15.2 Sarstedt Description and Business Overview
6.15.3 Sarstedt Lancets Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 Sarstedt Lancets Product Portfolio
6.15.5 Sarstedt Recent Developments/Updates
6.16 Sinocare
6.16.1 Sinocare Company Information
6.16.2 Sinocare Description and Business Overview
6.16.3 Sinocare Lancets Sales, Revenue, and Gross Margin (2021–2026)
6.16.4 Sinocare Lancets Product Portfolio
6.16.5 Sinocare Recent Developments/Updates
6.17 Yueyue Medical
6.17.1 Yueyue Medical Company Information
6.17.2 Yueyue Medical Description and Business Overview
6.17.3 Yueyue Medical Lancets Sales, Revenue, and Gross Margin (2021–2026)
6.17.4 Yueyue Medical Lancets Product Portfolio
6.17.5 Yueyue Medical Recent Developments/Updates
6.18 Tianjin Huahong Medical
6.18.1 Tianjin Huahong Medical Company Information
6.18.2 Tianjin Huahong Medical Description and Business Overview
6.18.3 Tianjin Huahong Medical Lancets Sales, Revenue, and Gross Margin (2021–2026)
6.18.4 Tianjin Huahong Medical Lancets Product Portfolio
6.18.5 Tianjin Huahong Medical Recent Developments/Updates
6.19 Suzhou Shilai Medical
6.19.1 Suzhou Shilai Medical Company Information
6.19.2 Suzhou Shilai Medical Description and Business Overview
6.19.3 Suzhou Shilai Medical Lancets Sales, Revenue, and Gross Margin (2021–2026)
6.19.4 Suzhou Shilai Medical Lancets Product Portfolio
6.19.5 Suzhou Shilai Medical Recent Developments/Updates
6.20 Shandong Lianfa Medical
6.20.1 Shandong Lianfa Medical Company Information
6.20.2 Shandong Lianfa Medical Description and Business Overview
6.20.3 Shandong Lianfa Medical Lancets Sales, Revenue, and Gross Margin (2021–2026)
6.20.4 Shandong Lianfa Medical Lancets Product Portfolio
6.20.5 Shandong Lianfa Medical Recent Developments/Updates
6.21 Promisemed
6.21.1 Promisemed Company Information
6.21.2 Promisemed Description and Business Overview
6.21.3 Promisemed Lancets Sales, Revenue, and Gross Margin (2021–2026)
6.21.4 Promisemed Lancets Product Portfolio
6.21.5 Promisemed Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Lancets Industry Chain Analysis
7.2 Lancets Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Lancets Production Mode & Process Analysis
7.4 Lancets Sales and Marketing
7.4.1 Lancets Sales Channels
7.4.2 Lancets Distributors
7.5 Lancets Customer Analysis
8 Lancets Market Dynamics
8.1 Lancets Industry Trends
8.2 Lancets Market Drivers
8.3 Lancets Market Challenges
8.4 Lancets Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Lancets Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Lancets Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Lancets Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Lancets Sales (M Units) of Key Manufacturers (2021–2026)
 Table 5. Global Lancets Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Lancets Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Lancets Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Lancets Average Price (US$/Unit) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Lancets, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Lancets, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Lancets, Product Types and Applications
 Table 12. Global Key Manufacturers of Lancets, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Lancets Companies by Tier (Tier 1, Tier 2, Tier 3), based on Lancets Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Lancets Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Lancets Sales by Region (M Units), 2021–2026
 Table 18. Global Lancets Sales Market Share by Region (2021–2026)
 Table 19. Global Lancets Sales by Region (M Units), 2027–2032
 Table 20. Global Lancets Sales Market Share by Region (2027–2032)
 Table 21. Global Lancets Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Lancets Revenue Market Share by Region (2021–2026)
 Table 23. Global Lancets Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Lancets Revenue Market Share by Region (2027–2032)
 Table 25. North America Lancets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Lancets Sales by Country (M Units), 2021–2026
 Table 27. North America Lancets Sales by Country (M Units), 2027–2032
 Table 28. North America Lancets Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Lancets Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Lancets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Lancets Sales by Country (M Units), 2021–2026
 Table 32. Europe Lancets Sales by Country (M Units), 2027–2032
 Table 33. Europe Lancets Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Lancets Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Lancets Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Lancets Sales by Region (M Units), 2021–2026
 Table 37. Asia Pacific Lancets Sales by Region (M Units), 2027–2032
 Table 38. Asia Pacific Lancets Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Lancets Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Lancets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Lancets Sales by Country (M Units), 2021–2026
 Table 42. Latin America Lancets Sales by Country (M Units), 2027–2032
 Table 43. Latin America Lancets Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Lancets Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Lancets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Lancets Sales by Country (M Units), 2021–2026
 Table 47. Middle East and Africa Lancets Sales by Country (M Units), 2027–2032
 Table 48. Middle East and Africa Lancets Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Lancets Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Lancets Sales (M Units) by Type (2021–2026)
 Table 51. Global Lancets Sales (M Units) by Type (2027–2032)
 Table 52. Global Lancets Sales Market Share by Type (2021–2026)
 Table 53. Global Lancets Sales Market Share by Type (2027–2032)
 Table 54. Global Lancets Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Lancets Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Lancets Revenue Market Share by Type (2021–2026)
 Table 57. Global Lancets Revenue Market Share by Type (2027–2032)
 Table 58. Global Lancets Price (US$/Unit) by Type (2021–2026)
 Table 59. Global Lancets Price (US$/Unit) by Type (2027–2032)
 Table 60. Global Lancets Sales (M Units) by Application (2021–2026)
 Table 61. Global Lancets Sales (M Units) by Application (2027–2032)
 Table 62. Global Lancets Sales Market Share by Application (2021–2026)
 Table 63. Global Lancets Sales Market Share by Application (2027–2032)
 Table 64. Global Lancets Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Lancets Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Lancets Revenue Market Share by Application (2021–2026)
 Table 67. Global Lancets Revenue Market Share by Application (2027–2032)
 Table 68. Global Lancets Price (US$/Unit) by Application (2021–2026)
 Table 69. Global Lancets Price (US$/Unit) by Application (2027–2032)
 Table 70. Roche Company Information
 Table 71. Roche Description and Business Overview
 Table 72. Roche Lancets Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 73. Roche Lancets Product
 Table 74. Roche Recent Developments/Updates
 Table 75. Lifescan Company Information
 Table 76. Lifescan Description and Business Overview
 Table 77. Lifescan Lancets Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 78. Lifescan Lancets Product
 Table 79. Lifescan Recent Developments/Updates
 Table 80. BD Company Information
 Table 81. BD Description and Business Overview
 Table 82. BD Lancets Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 83. BD Lancets Product
 Table 84. BD Recent Developments/Updates
 Table 85. MTD Group Company Information
 Table 86. MTD Group Description and Business Overview
 Table 87. MTD Group Lancets Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 88. MTD Group Lancets Product
 Table 89. MTD Group Recent Developments/Updates
 Table 90. Greiner Bio One Company Information
 Table 91. Greiner Bio One Description and Business Overview
 Table 92. Greiner Bio One Lancets Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 93. Greiner Bio One Lancets Product
 Table 94. Greiner Bio One Recent Developments/Updates
 Table 95. Owen Mumford Company Information
 Table 96. Owen Mumford Description and Business Overview
 Table 97. Owen Mumford Lancets Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 98. Owen Mumford Lancets Product
 Table 99. Owen Mumford Recent Developments/Updates
 Table 100. Cardinal Health Company Information
 Table 101. Cardinal Health Description and Business Overview
 Table 102. Cardinal Health Lancets Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 103. Cardinal Health Lancets Product
 Table 104. Cardinal Health Recent Developments/Updates
 Table 105. Ascensia Company Information
 Table 106. Ascensia Description and Business Overview
 Table 107. Ascensia Lancets Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 108. Ascensia Lancets Product
 Table 109. Ascensia Recent Developments/Updates
 Table 110. Abbott Company Information
 Table 111. Abbott Description and Business Overview
 Table 112. Abbott Lancets Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 113. Abbott Lancets Product
 Table 114. Abbott Recent Developments/Updates
 Table 115. B. Braun Company Information
 Table 116. B. Braun Description and Business Overview
 Table 117. B. Braun Lancets Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 118. B. Braun Lancets Product
 Table 119. B. Braun Recent Developments/Updates
 Table 120. Terumo Company Information
 Table 121. Terumo Description and Business Overview
 Table 122. Terumo Lancets Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 123. Terumo Lancets Product
 Table 124. Terumo Recent Developments/Updates
 Table 125. I-SENS Company Information
 Table 126. I-SENS Description and Business Overview
 Table 127. I-SENS Lancets Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 128. I-SENS Lancets Product
 Table 129. I-SENS Recent Developments/Updates
 Table 130. Nipro Company Information
 Table 131. Nipro Description and Business Overview
 Table 132. Nipro Lancets Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 133. Nipro Lancets Product
 Table 134. Nipro Recent Developments/Updates
 Table 135. ICU Medical Company Information
 Table 136. ICU Medical Description and Business Overview
 Table 137. ICU Medical Lancets Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 138. ICU Medical Lancets Product
 Table 139. ICU Medical Recent Developments/Updates
 Table 140. Sarstedt Company Information
 Table 141. Sarstedt Description and Business Overview
 Table 142. Sarstedt Lancets Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 143. Sarstedt Lancets Product
 Table 144. Sarstedt Recent Developments/Updates
 Table 145. Sinocare Company Information
 Table 146. Sinocare Description and Business Overview
 Table 147. Sinocare Lancets Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 148. Sinocare Lancets Product
 Table 149. Sinocare Recent Developments/Updates
 Table 150. Yueyue Medical Company Information
 Table 151. Yueyue Medical Description and Business Overview
 Table 152. Yueyue Medical Lancets Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 153. Yueyue Medical Lancets Product
 Table 154. Yueyue Medical Recent Developments/Updates
 Table 155. Tianjin Huahong Medical Company Information
 Table 156. Tianjin Huahong Medical Description and Business Overview
 Table 157. Tianjin Huahong Medical Lancets Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 158. Tianjin Huahong Medical Lancets Product
 Table 159. Tianjin Huahong Medical Recent Developments/Updates
 Table 160. Suzhou Shilai Medical Company Information
 Table 161. Suzhou Shilai Medical Description and Business Overview
 Table 162. Suzhou Shilai Medical Lancets Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 163. Suzhou Shilai Medical Lancets Product
 Table 164. Suzhou Shilai Medical Recent Developments/Updates
 Table 165. Shandong Lianfa Medical Company Information
 Table 166. Shandong Lianfa Medical Description and Business Overview
 Table 167. Shandong Lianfa Medical Lancets Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 168. Shandong Lianfa Medical Lancets Product
 Table 169. Shandong Lianfa Medical Recent Developments/Updates
 Table 170. Promisemed Company Information
 Table 171. Promisemed Description and Business Overview
 Table 172. Promisemed Lancets Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 173. Promisemed Lancets Product
 Table 174. Promisemed Recent Developments/Updates
 Table 175. Key Raw Materials Lists
 Table 176. Raw Materials Key Suppliers Lists
 Table 177. Lancets Distributors List
 Table 178. Lancets Customers List
 Table 179. Lancets Market Trends
 Table 180. Lancets Market Drivers
 Table 181. Lancets Market Challenges
 Table 182. Lancets Market Restraints
 Table 183. Research Programs/Design for This Report
 Table 184. Key Data Information from Secondary Sources
 Table 185. Key Data Information from Primary Sources
 Table 186. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Lancets
 Figure 2. Global Lancets Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Lancets Market Share by Type: 2025 & 2032
 Figure 4. Safety Lancets Product Picture
 Figure 5. Ordinary Lancets Product Picture
 Figure 6. Global Lancets Market Value by Application (US$ Million), 2021–2032
 Figure 7. Global Lancets Market Share by Application: 2025 & 2032
 Figure 8. Blood Glucose Test
 Figure 9. Newborn Screening
 Figure 10. Rapid Blood Test
 Figure 11. Other
 Figure 12. Global Lancets Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 13. Global Lancets Market Size (US$ Million), 2021–2032
 Figure 14. Global Lancets Sales (M Units), 2021–2032
 Figure 15. Global Lancets Average Price (US$/Unit), 2021–2032
 Figure 16. Lancets Report Years Considered
 Figure 17. Lancets Sales Share by Manufacturers in 2025
 Figure 18. Global Lancets Revenue Share by Manufacturers in 2025
 Figure 19. Top 5 and Top 10 Global Lancets Players: Market Share by Revenue in Lancets in 2025
 Figure 20. Lancets Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 21. Global Lancets Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 22. North America Lancets Sales Market Share by Country (2021–2032)
 Figure 23. North America Lancets Revenue Market Share by Country (2021–2032)
 Figure 24. U.S. Lancets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 25. Canada Lancets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 26. Europe Lancets Sales Market Share by Country (2021–2032)
 Figure 27. Europe Lancets Revenue Market Share by Country (2021–2032)
 Figure 28. Germany Lancets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. France Lancets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. U.K. Lancets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Italy Lancets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Russia Lancets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 33. Asia Pacific Lancets Sales Market Share by Region (2021–2032)
 Figure 34. Asia Pacific Lancets Revenue Market Share by Region (2021–2032)
 Figure 35. China Lancets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. Japan Lancets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. South Korea Lancets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. India Lancets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. Australia Lancets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. China Taiwan Lancets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Indonesia Lancets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. Thailand Lancets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. Malaysia Lancets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Latin America Lancets Sales Market Share by Country (2021–2032)
 Figure 45. Latin America Lancets Revenue Market Share by Country (2021–2032)
 Figure 46. Mexico Lancets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Brazil Lancets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. Argentina Lancets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 49. Middle East and Africa Lancets Sales Market Share by Country (2021–2032)
 Figure 50. Middle East and Africa Lancets Revenue Market Share by Country (2021–2032)
 Figure 51. Turkey Lancets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. Saudi Arabia Lancets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. UAE Lancets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 54. Global Sales Market Share of Lancets by Type (2021–2032)
 Figure 55. Global Revenue Market Share of Lancets by Type (2021–2032)
 Figure 56. Global Lancets Price (US$/Unit) by Type (2021–2032)
 Figure 57. Global Sales Market Share of Lancets by Application (2021–2032)
 Figure 58. Global Revenue Market Share of Lancets by Application (2021–2032)
 Figure 59. Global Lancets Price (US$/Unit) by Application (2021–2032)
 Figure 60. Lancets Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Strategic Venue Partners